Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain (Q56766158)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1993

edit

Language	Label	Description	Also known as
English	Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain	scientific article published on 01 August 1993

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

retracted paper

2 references

stated in

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

stated in

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

main subject

endometriosis

1 reference

based on heuristic

inferred from title

author name string

A J Friedman

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

M D Hornstein

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

language of work or name

English

0 references

publication date

1 August 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

published in

Fertility and Sterility

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

volume

60

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

page(s)

236-241

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

cites work

A comparison of nafarelin acetate and danazol in the treatment of endometriosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Should perimenopausal women be screened for osteoporosis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

The reproducibility of the revised American Fertility Society classification of endometriosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0015-0282(16)56090-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

PubMed publication ID

8339817

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8339817

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56766158&oldid=2216705040"